XTX Topco’s CVS Health CVS Stock Holding History

XTX Topco’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,774	Closed	-$1.25M	–	3919
2025 Q4	$1.25M	Buy	+15,774	New	+$1.24M	0.03%	868
2025 Q2	–	Sell	-31,516	Closed	-$2.14M	–	2505
2025 Q1	$2.14M	Buy	+31,516	New	+$1.89M	0.11%	238
2024 Q4	–	Sell	-32,701	Closed	-$2.06M	–	2402
2024 Q3	$2.06M	Sell	32,701 -21,521	-40%	-$1.26M	0.15%	139
2024 Q2	$3.2M	Buy	54,222 +41,854	+338%	+$2.62M	0.27%	41
2024 Q1	$986K	Buy	12,368 +9,713	+366%	+$742K	0.13%	165
2023 Q4	$210K	Buy	+2,655	New	+$189K	0.05%	927
2023 Q3	–	Sell	-13,378	Closed	-$925K	–	1639
2023 Q2	$925K	Buy	13,378 +2,691	+25%	+$191K	0.17%	106
2023 Q1	$794K	Sell	10,687 -2,936	-22%	-$246K	0.17%	97
2022 Q4	$1.27M	Buy	13,623 +10,849	+391%	+$1.05M	0.27%	51
2022 Q3	$265K	Buy	+2,774	New	+$275K	0.07%	588
2022 Q2	–	Sell	-7,487	Closed	-$758K	–	898
2022 Q1	$758K	Buy	7,487 +3,523	+89%	+$370K	0.33%	63
2021 Q4	$409K	Sell	3,964 -264	-6%	-$24.4K	0.23%	110
2021 Q3	$359K	Buy	+4,228	New	+$354K	0.12%	288

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

XTX Topco's CVS Position: Q1 2026 in Review

XTX Topco sold out of CVS Health (CVS) in Q1 2026, closing a stake of 15,774 shares — an estimated $1.25M sold.

XTX Topco first reported a position in CVS in Q3 2021 and held it in 13 quarters. The position peaked at $3.2M in Q2 2024. 1,866 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

XTX Topco reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
XTX Topco sold 15,774 CVS Health shares in Q1 2026, an estimated $1.25M.
XTX Topco first reported a position in CVS Health in Q3 2021 and held it in 13 quarters.
XTX Topco's CVS Health position peaked at $3.2M in Q2 2024.
1,866 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.